investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Melanoma RAS/BRAF Mutation: Heterogeneity-Risk-Prognosis
Nancy E Thomas
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Bruce Armstrong
University of Sydney
Sydney, Australia
Collaborator from Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
New York, United States
Nancy E Thomas
University of North Carolina at Chapel Hill
Chapel Hill, United States
Related projects
Jeffrey N Martin
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer - Uganda, Kenya, San Francisco
Melanoma of skin
Pathology
Eric T Wong
The Role of Post Traumatic Stress and Substance P in Melanoma Brain Metastasis
Melanoma of skin
Pathology
James Q Zheng
Mechanism of growth cone turning in diffusible gradients
Melanoma of skin
Pathology
Mark B Faries
Multicenter Selective Lymphadenectomy Trial (MSLT II) in Melanoma
Melanoma of skin
Pathology
Eva Hernando
Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis
Melanoma of skin
Pathology
John B Sunwoo
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses
Melanoma of skin
Pathology
Hassane M Zarour
Reversing melanoma-induced T cell dysfunction
Melanoma of skin
Pathology
Charles J Dimitroff
Functional Analysis of Galectin-1 Ligands in Melanoma Progression
Melanoma of skin
Pathology
Peter Kanetzsky
GenoMEL, the Melanoma Genetics Consortium: Investigations of the Impact of Genetics and Sun Exposure on Melanoma Development
Melanoma of skin
Pathology
